Statements (67)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:virus
|
| gptkbp:associated_with |
gptkb:multicentric_Castleman_disease
gptkb:primary_effusion_lymphoma gptkb:chronic_fatigue_syndrome gptkb:endemic_Kaposi's_sarcoma gptkb:Oncology gptkb:anemia gptkb:HIV/_AIDS autoimmune diseases thrombosis chronic inflammation hemolytic anemia thrombocytopenia opportunistic infections immunosuppression gastrointestinal complications neurocognitive disorders pulmonary complications hepatomegaly splenomegaly lymphoproliferative disorders leukopenia secondary malignancies renal complications epidemic Kaposi's sarcoma lymphatic disorders transplant patients viral co-infections |
| gptkbp:belongs_to |
Herpesviridae family
|
| gptkbp:cause |
gptkb:Kaposi's_sarcoma
|
| gptkbp:clinical_trial |
oncogenic virus
|
| gptkbp:diagnosis |
serological tests
PCR testing |
| gptkbp:discovered_by |
gptkb:1994
|
| gptkbp:discovery_year |
gptkb:1994
|
| gptkbp:diseases |
B cells
endothelial cells |
| gptkbp:epidemiology |
more common in immunocompromised individuals
associated with HIV co-infection endemic in certain regions of Africa |
| https://www.w3.org/2000/01/rdf-schema#label |
Human Herpesvirus 8
|
| gptkbp:is_vulnerable_to |
no approved vaccine
|
| gptkbp:prevention |
safe sex practices
organ donor screening blood safety measures screening in high-risk populations |
| gptkbp:propagation_method |
organ transplantation
sexual contact blood transfusion |
| gptkbp:replaces |
Kaposi's sarcoma patient
|
| gptkbp:reprints |
gptkb:Atom
|
| gptkbp:research_focus |
immune response
treatment strategies viral pathogenesis |
| gptkbp:seed_dispersal |
double-stranded DNA
approximately 165 kb |
| gptkbp:symptoms |
fever
skin lesions lymphadenopathy |
| gptkbp:treatment |
gptkb:immunotherapy
gptkb:surgery radiation therapy chemotherapy targeted therapy antiviral therapy |
| gptkbp:bfsParent |
gptkb:Kaposi's_sarcoma
|
| gptkbp:bfsLayer |
4
|